Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Sangro

Showing results (21-30 of 329) with videos related to

Pageof 33
Sort By:
The International Journal of Biochemistry & Cell Biology|December 14, 2002
Gene therapy of neoplastic liver diseasesBruno Sangro, Maite Herraiz, Jesus Prieto
Journal of Hepatology|March 13, 2017
Assessment of treatment efficacy in hepatocellular carcinoma: Response rate, delay in progression or none of themJordi Bruix, Maria Reig, Bruno Sangro
European Journal of Gastroenterology & Hepatology|April 14, 2005
Future therapies for hepatocellular carcinomaBruno Sangro, Guillermo Mazzollini, Jesus Prieto
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2017
Immunotherapy of Hepatocellular Carcinoma: Facts and HopesMercedes Iñarrairaegui, Ignacio Melero, Bruno Sangro
Nature Reviews. Gastroenterology & Hepatology|October 21, 2015
Immunological landscape and immunotherapy of hepatocellular carcinomaJesús Prieto, Ignacio Melero, Bruno Sangro
JAMA Oncology|January 11, 2024
HIMALAYA Overall Survival Prominence and Other Routes to the PeakGhassan K Abou-Alfa, Bruno Sangro
Medicina|September 28, 2002
[In vivo evaluation of gene transfer]Guillermo Mazzolini, Bruno Sangro, Jesús Prieto
Cardiovascular and Interventional Radiology|June 10, 2022
How Could <sup>90</sup>Y-Loaded Microsphere Distribution Be Optimized?Jorge Aramburu, Raúl Antón, Bruno Sangro
Hepatology (Baltimore, Md.)|March 21, 2013
Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons, current challenges, and clinical perspectivesRiad Salem, Vincenzo Mazzaferro, Bruno Sangro
Hepatic Oncology|September 8, 2018
Immunotherapy of hepatocellular carcinomaBruno Sangro, Daniel Palmer, Ignacio Melero
Pageof 33

Showing results (21-30 of 329) with videos related to

Sort By:
Pageof 33
The International Journal of Biochemistry & Cell Biology|December 14, 2002
Gene therapy of neoplastic liver diseasesBruno Sangro, Maite Herraiz, Jesus Prieto
Journal of Hepatology|March 13, 2017
Assessment of treatment efficacy in hepatocellular carcinoma: Response rate, delay in progression or none of themJordi Bruix, Maria Reig, Bruno Sangro
European Journal of Gastroenterology & Hepatology|April 14, 2005
Future therapies for hepatocellular carcinomaBruno Sangro, Guillermo Mazzollini, Jesus Prieto
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2017
Immunotherapy of Hepatocellular Carcinoma: Facts and HopesMercedes Iñarrairaegui, Ignacio Melero, Bruno Sangro
Nature Reviews. Gastroenterology & Hepatology|October 21, 2015
Immunological landscape and immunotherapy of hepatocellular carcinomaJesús Prieto, Ignacio Melero, Bruno Sangro
JAMA Oncology|January 11, 2024
HIMALAYA Overall Survival Prominence and Other Routes to the PeakGhassan K Abou-Alfa, Bruno Sangro
Medicina|September 28, 2002
[In vivo evaluation of gene transfer]Guillermo Mazzolini, Bruno Sangro, Jesús Prieto
Cardiovascular and Interventional Radiology|June 10, 2022
How Could <sup>90</sup>Y-Loaded Microsphere Distribution Be Optimized?Jorge Aramburu, Raúl Antón, Bruno Sangro
Hepatology (Baltimore, Md.)|March 21, 2013
Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons, current challenges, and clinical perspectivesRiad Salem, Vincenzo Mazzaferro, Bruno Sangro
Hepatic Oncology|September 8, 2018
Immunotherapy of hepatocellular carcinomaBruno Sangro, Daniel Palmer, Ignacio Melero
Pageof 33